1.
免疫组化检测肺癌中PRDM14的表达与临床病理学特征的关系
The expressions of PRDM14 and clinicopathologic characteristics in lung squamous cell carcinoma and adenocarcinoma
| Characteristics | n | Expression of PRDM14 | Z | X2 | P | |||
| Negative | Weak | Moderate | Strong | |||||
| Gender | -0.484 | 0.629 | ||||||
| Male | 40 | 2 | 5 | 25 | 9 | |||
| Female | 30 | 6 | 4 | 11 | 8 | |||
| Age | -1.531 | 0.126 | ||||||
| <59 years | 28 | 6 | 4 | 11 | 8 | |||
| ≥59 years | 42 | 2 | 5 | 25 | 9 | |||
| TNM stage | 5.900 | 0.052 | ||||||
| Ⅰ | 23 | 2 | 4 | 13 | 4 | |||
| Ⅱ | 22 | 0 | 0 | 13 | 7 | |||
| Ⅲ-Ⅳ | 25 | 6 | 5 | 2 | 12 | |||
| Differentiation | 6.147 | 0.046 | ||||||
| Highly differentiated | 13 | 2 | 2 | 7 | 0 | |||
| Moderately differentiated | 40 | 6 | 5 | 18 | 11 | |||
| Poorly differentiated | 17 | 0 | 2 | 3 | 12 | |||
| Histological type | -1.982 | 0.047 | ||||||
| Squamous cell carcinoma | 26 | 5 | 3 | 8 | 8 | |||
| Adencarcinoma | 44 | 6 | 6 | 20 | 15 | |||
| Lymphnode metastasis | -1.174 | 0.240 | ||||||
| No | 30 | 4 | 4 | 13 | 8 | |||
| Yes | 40 | 4 | 5 | 15 | 15 | |||